Medication adherence and persistence in chronic obstructive pulmonary disease patients receiving triple therapy in a USA commercially insured population

References

• GOLD [homepage on the Internet]Global strategy for the diagnosis, management and prevention of COPD2018 Available from: http://goldcopd.orgAccessed May 23, 2018
   Google Scholar
• CDC [homepage on the Internet]Chronic Obstructive Pulmonary Disease (COPD). National Center for Chronic Disease Prevention and Health Promotion Division of Population Health [updated June 6, 2018] Available from: www.cdc.gov/copd/index.htmlAccessed July 2, 2018
   Google Scholar
• CazzolaMAndòFSantusPA pilot study to assess the effects of combining fluticasone propionate/salmeterol and tiotropium on the airflow obstruction of patients with severe-to-very severe COPDPulm Pharmacol Ther200720555656116914336
   PubMed Web of Science ®Google Scholar
• HananiaNACraterGDMorrisANEmmettAHO’DellDMNiewoehnerDEBenefits of adding fluticasone propionate/salmeterol to tiotropium in moderate to severe COPDRespir Med201210619110122040533
   PubMed Web of Science ®Google Scholar
• JungKSParkHYParkSYComparison of tiotropium plus fluticasone propionate/salmeterol with tiotropium in COPD: a randomized controlled studyRespir Med2012106338238921975275
   PubMed Web of Science ®Google Scholar
• WelteTMiravitllesMHernandezPEfficacy and tolerability of budesonide/formoterol added to tiotropium in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2009180874175019644045
   PubMed Web of Science ®Google Scholar
• ChatterjeeAShahMD’SouzaAOBechtelBCraterGDalalAAObservational study on the impact of initiating tiotropium alone versus tiotropium with fluticasone propionate/salmeterol combination therapy on outcomes and costs in chronic obstructive pulmonary diseaseRespir Res20121311522340019
   PubMed Web of Science ®Google Scholar
• ShortPMWilliamsonPAElderDHJLipworthSIWSchembriSLipworthBJThe impact of tiotropium on mortality and exacerbations when added to inhaled corticosteroids and long-acting β-agonist therapy in COPDChest20121411818621799028
   PubMed Web of Science ®Google Scholar
• WedzichaJADecramerMFickerJHAnalysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): a randomised, double-blind, parallel-group studyLancet Respir Med20131319920924429126
   PubMed Web of Science ®Google Scholar
• SinghDPapiACorradiMSingle inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trialLancet20163881004896397327598678
   PubMed Web of Science ®Google Scholar
• SilerTMKerwinESousaARDonaldAAliRChurchAEfficacy and safety of umeclidinium added to fluticasone furoate/vilanterol in chronic obstructive pulmonary disease: results of two randomized studiesRespir Med201510991155116326117292
   PubMed Web of Science ®Google Scholar
• VestboJPapiACorradiMSingle inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trialLancet2017389100821919192928385353
   PubMed Web of Science ®Google Scholar
• LipsonDABarnacleHBirkRFULFIL trial: Once-daily triple therapy for patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2017196443844628375647
   PubMed Web of Science ®Google Scholar
• Bosnic-AnticevichSChrystynHCostelloRWThe use of multiple respiratory inhalers requiring different inhalation techniques has an adverse effect on COPD outcomesInt J Chron Obstruct Pulmon Dis201712597128053517
   PubMed Web of Science ®Google Scholar
• MolimardMColthorpePInhaler devices for chronic obstructive pulmonary disease: insights from patients and healthcare practitionersJ Aerosol Med Pulm Drug Deliv201528321922825265316
   PubMed Web of Science ®Google Scholar
• RauJLDeterminants of patient adherence to an aerosol regimenRespir Care200550101346135616185370
   PubMedGoogle Scholar
• KruegerKPBergerBAFelkeyBMedication adherence and persistence: a comprehensive reviewAdv Ther200522431335616418141
   PubMed Web of Science ®Google Scholar
• ToyELBeaulieuNUMchaleJMTreatment of COPD: relationships between daily dosing frequency, adherence, resource use, and costsRespir Med2011105343544120880687
   PubMed Web of Science ®Google Scholar
• CramerJARoyABurrellAMedication compliance and persistence: terminology and definitionsValue Health2008111444718237359
   PubMed Web of Science ®Google Scholar
• BenderBGHernandez VecinoRAMcgrathKJonesSComparative analysis of persistence to treatment among patients with asthma or COPD receiving AirFluSal forspiro or seretide diskus salmeterol/fluticasone propionate combination therapyJ Allergy Clin Immunol Pract20164588488927587319
   PubMed Web of Science ®Google Scholar
• MäkeläMJBackerVHedegaardMLarssonKAdherence to inhaled therapies, health outcomes and costs in patients with asthma and COPDRespir Med2013107101481149023643487
   PubMed Web of Science ®Google Scholar
• XieLFrech-TamasFMarrettEBaserOA medication adherence and persistence comparison of hypertensive patients treated with single-, double- and triple-pill combination therapyCurr Med Res Opin201430122415242225222764
   PubMed Web of Science ®Google Scholar
• PanjabiSLaceyMBancroftTCaoFTreatment adherence, clinical outcomes, and economics of triple-drug therapy in hypertensive patientsJ Am Soc Hypertens201371466023321404
   PubMed Web of Science ®Google Scholar
• BonafedeMJohnsonBHTangDHShahNHarrisonDJCollierDHEtanercept-methotrexate combination therapy initiators have greater adherence and persistence than triple therapy initiators with rheumatoid arthritisArthritis Care Res2015671216561663
   Web of Science ®Google Scholar
• QuanHSundararajanVHalfonPCoding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative dataMed Care200543111130113916224307
   PubMed Web of Science ®Google Scholar
• ElixhauserASteinerCHarrisDRCoffeyRMComorbidity measures for use with administrative dataMed Care19983618279431328
   PubMed Web of Science ®Google Scholar
• DolceJJCrispCManzellaBRichardsJMHardinJMBaileyWCMedication adherence patterns in chronic obstructive pulmonary diseaseChest19919948378412009784
   PubMed Web of Science ®Google Scholar
• RestrepoRDAlvarezMTWittnebelLDMedication adherence issues in patients treated for COPDInt J Chron Obstruct Pulmon Dis20083337138418990964
   PubMedGoogle Scholar
• MartinLRWilliamsSLHaskardKBDimatteoMRThe challenge of patient adherenceTher Clin Risk Manag20051318919918360559
   PubMedGoogle Scholar
• KarnerCCatesCJLong-acting beta2-agonist in addition to tiotropium versus either tiotropium or long-acting beta2-agonist alone for chronic obstructive pulmonary diseaseCochrane Database Syst Rev201110CD008532
   Google Scholar
• MontuschiPMalerbaMMacisGMoresNSantiniGTriple inhaled therapy for chronic obstructive pulmonary diseaseDrug Discov Today201621111820182727452453
   PubMed Web of Science ®Google Scholar
• SimeoneJLuthraRKailaSInitiation of triple therapy maintenance treatment among patients with COPD in the USInter J Chron Obstruct Pulmon Dis2017127383
   PubMed Web of Science ®Google Scholar
• BrusselleGPriceDGruffydd-JonesKThe inevitable drift to triple therapy in COPD: an analysis of prescribing pathways in the UKInter J Chron Obstruct Pulmon Dis20151022072217
   PubMed Web of Science ®Google Scholar
• WurstKEPunekarYSShuklaATreatment evolution after COPD diagnosis in the UK primary care settingPLoS One201499e10529625180802
   PubMed Web of Science ®Google Scholar
• AlbertsonTMurinSHarperRSandrockCPatient considerations in the treatment of COPD: focus on the new combination inhaler ume-clidinium/vilanterolPatient Prefer Adherence2015923524225673975
   PubMed Web of Science ®Google Scholar
• ÁghTInotaiAMészárosÁFactors associated with medication adherence in patients with chronic obstructive pulmonary diseaseRespiration201182432833421454953
   PubMed Web of Science ®Google Scholar
• BryantJMcDonaldVMBoyesASanson-FisherRPaulCMelvilleJImproving medication adherence in chronic obstructive pulmonary disease: a systematic reviewRespir Res201314110924138097
   PubMed Web of Science ®Google Scholar
• LareauSCYawnBPImproving adherence with inhaler therapy in COPDInt J Chron Obstruct Pulmon Dis2010540140621191434
   PubMedGoogle Scholar
• SanduzziABalboPCandoliPCOPD: adherence to therapyMultidiscip Respir Med2014916025485108
   PubMedGoogle Scholar
• DhamaneADSchwabPHopsonSAssociation between adherence to medications for COPD and medications for other chronic conditions in COPD patientsInt J Chron Obstruct Pulmon Dis20171211512228053521
   PubMed Web of Science ®Google Scholar
• MuellerSWilkeTBechtelBPunekarYSMitznerKVirchowJCNon-persistence and non-adherence to long-acting COPD medication therapy: a retrospective cohort study based on a large German claims datasetRespir Med201712211127993284
   PubMed Web of Science ®Google Scholar
• ÁghTDömötörPBártfaiZInotaiAFujszEMészárosÁRelationship between medication adherence and health-related quality of life in subjects with COPD: a systematic reviewRespir Care201560229730325185152
   PubMed Web of Science ®Google Scholar
• van BovenJFChavannesNHvan der MolenTRutten-van MölkenMPPostmaMJVegterSClinical and economic impact of non-adherence in COPD: a systematic reviewRespir Med2014a108110311324070566
   PubMed Web of Science ®Google Scholar
• DavisJRWuBKernDMImpact of nonadherence to inhaled corticosteroid/LABA therapy on COPD exacerbation rates and health-care costs in a commercially insured US populationAm Health Drug Benefits20171029210228626506
   PubMed Web of Science ®Google Scholar
• van BovenJFMvan RaaijJJvan der GaliënRImpact of multiple-dose versus single-dose inhaler devices on COPD patients’ persistence with long-acting β2-agonists: a dispensing database analysisNPJ Prim Care Resp Med2014b24114069
   Web of Science ®Google Scholar
• ChoudhryNKShrankWHLevinRLMeasuring concurrent adherence to multiple related medicationsAm J Manag Care200915745746419589013
   PubMed Web of Science ®Google Scholar
• BergKMArnstenJHPractical and conceptual challenges in measuring antiretroviral adherenceJ Acquir Immune Defic Syndr200643Suppl 1S79S8717133207
   PubMed Web of Science ®Google Scholar
• BogartMLalibertéFDuhMSWuJWGermainGStanfordRHMedication adherence and persistence in chronic obstructive pulmonary disease (COPD) patients on triple therapy in a US commercially insured populationAm J Respir Crit Care Med2018197A2502
   Web of Science ®Google Scholar